Novel RT-ddPCR Assays for determining the transcriptional profile of SARS-CoV-2

bioRxiv [Preprint]. 2021 Jan 12:2021.01.12.425991. doi: 10.1101/2021.01.12.425991.

Abstract

The exact mechanism of coronavirus replication and transcription is not fully understood; however, a hallmark of coronavirus transcription is the generation of negative-sense RNA intermediates that serve as the templates for the synthesis of positive-sense genomic RNA (gRNA) and an array of subgenomic mRNAs (sgRNAs) encompassing sequences arising from discontinuous transcription. Existing PCR-based diagnostic assays for SAR-CoV-2 are qualitative or semi-quantitative and do not provide the resolution needed to assess the complex transcription dynamics of SARS-CoV-2 over the course of infection. We developed and validated a novel panel of specially designed SARS-CoV-2 ddPCR-based assays to map the viral transcription profile. Application of these assays to clinically relevant samples will enhance our understanding of SARS-CoV-2 replication and transcription and may also inform the development of improved diagnostic tools and therapeutics.

Keywords: SARS-CoV-2; coronavirus; droplet-digital PCR; quantitative assays; viral transcription/replication.

Publication types

  • Preprint